Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

09997 Kangji Medical Holdings

Watchlist
8.1500.0000.00%
Pre-Market Auction Session  12/06 09:00 CCT
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
8.150
Volume
0.00
Market Cap
10.02B
P/E(TTM)
19.93
52wk High
8.978
Shares
1.23B
P/E(Static)
17.95
52wk Low
5.280
Float Cap
10.02B
Bid/Ask %
1.27%
Historical High
35.434
Shs Float
1.23B
Volume Ratio
0.00
Historical Low
5.280
Dividend TTM
0.174
Div Yield TTM
0.174
P/B
2.58
Dividend LFY
2.13%
Div Yield LFY
2.13%
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
500
Float Cap
10.02B
Bid/Ask %
1.27%
Historical High
35.434
Shs Float
1.23B
Volume Ratio
0.00
Historical Low
5.280
Dividend TTM
0.174
P/B
2.58
Dividend LFY
2.13%
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
--
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
The Group was founded in August 2004 in Hangzhou Kangji Medical equipment Co., Ltd. ("Hangzhou Kangji", "Company"). Hangzhou Kangji is a high-tech enterprise specializing in R & D, production and sales of minimally invasive surgical instruments and matching consumables (MISIA). It is the backbone enterprise of China Medical Endoscope Industry Base (Tonglu), the director unit of China Medical equipment Association, the director unit of China Medical device Industry Association, the vice chairman unit of Zhejiang Medical device Industry Association, and the chairman unit of Tonglu Medical device Industry Association. With the mission of "providing quality products and services for doctors and committed to the cause of human health", the Group is committed to becoming a platform for minimally invasive surgical instruments and consumables (MISIA) in China, providing one-stop solutions for minimally invasive surgery in clinical departments such as obstetrics and gynaecology, general surgery, urology and thoracic surgery through a rich product portfolio. Hangzhou Kang Infrastructure has industry-university-research platforms such as provincial academician expert workstations, provincial enterprise research institutes and enterprise high-tech research centers to develop a variety of MISIA products that meet clinical needs. The company has established a sound quality management system, and has passed ENISO 13485, ISO 9001 international quality management system certification, ISO 45001 occupational health and safety management system certification and ISO 14001 chemical management system certification. The company's main products have passed the CE certification. Through its extensive sales network, the company's products are sold to more than 3400 hospitals (including more than 1000 first-class hospitals) in China, covering all provinces, municipalities and autonomous regions of Chinese mainland, and to 42 other countries and regions at the same time.
CEO: Ming Zhong
Market: Hong Kong motherboard
Listing Date: 06/29/2020
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist